Table 2

Hearing aid studies and indicators

Study designCohortCross-sectionalMixed-methodsSecondary cross-sectionalTotal
 N1911425
 %4%36%4%56%100%
Assessment approachesClinical onlySelf-report onlyFunctional onlyClinical and self-reportClinical and functionalOther combinationSecondary sources (multiple)
 N2401422125
 %8%16%0%56%8%8%4%100%
Participants (N)*<500500–9991000–49995000–999910 000–24 999>25 000Not available
 N3111234125
 %12%4%44%8%12%16%4%100%
Age (years) included†Under 15<15 to 85+15 to 85+40 to 85+65 to 85+Over 85
 N17547125
 %4%28%20%28%28%4%100%
JBI score<778910
 N11551325
 %4%4%20%20%52%100%
Functioning difficulty or impairment definitionUse of APReported activity limitationsClinical thresholdCombination
 N3514325
 %12%20%56%12%100%
WHO RegionAFRAMREMREURSEARWPRGlobal
 N3101838134
 %9%29%3%24%9%24%3%100%
AP access indicatorTotal needMet needUnmet needUndermet needCoverageUseHas AP
 N71170226962
 %11%2%27%0%3%42%15%100%
Indicator denominatorTotal with/using APTotal with needTotal with functioning difficultyTotal participantsTotal population
 N1201524262
 %2%32%24%39%3%100%
  • *Participants (N) ranged from 379 to 4 55 200 for this domain.

  • †Age group boundaries varied considerably by study; studies are sorted into categories that most closely represent their included age boundaries.

  • AFR, African Region; AMR, Region of the Americas; AP, assistive product; EMR, Eastern Mediterranean Region; EUR, European Region; JBI, Joanna Briggs Institute; SEAR, Southeast Asian Region; WPR, Western Pacific Region.